Click here to read the articles and download the PDF

Pharmaceutical Commerce - December 2024

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Did Industry Fumble the DSCSA Deadline?

A crash course on the bubble itself, including therapeutic areas most affected.

Going Inside the Gross-to-Net Bubble and Its Nuances

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Why AI Advances in CGT Require Getting Data Right

Articles

IPX203—an oral formulation carbidopa/levodopa extended-release capsules —would expand Zambon’s neurology portfolio. 


 Amneal, Zambon Biotech Enter Exclusive European Licensing Agreement for Parkinson’s Disease Medication

Podcasts

Rob Besse offers a breakdown of the third-party logistics (3PL) process, including lessons that these providers have learned coming out of the pandemic.  

A First-Hand Account of 3PLs

Videos

In an interview with Pharma Commerce Associate Editor Don Tracy, Corey Ford, VP, Reimbursement & Policy Insights, Cencora, offers his thoughts on where the Inflation Reduction Act will be five to 10 years from now. 

Cencora's Corey Ford Discusses the Future of the Inflation Reduction Act

A Carrum Health/PWC report surveys benefit managers spanning various self-insured employers in an effort to determine ways to improve the cancer treatment experience, especially from a cost perspective. 

Finding the Ideal Set of Oncology Employer Benefits 

An MDVIP study reports that 61% of people feel hassled by the current structure. 


Survey Reveals Americans’ Frustrations With the Healthcare System

In an interview with Pharma Commerce Associate Editor Don Tracy, Corey Ford, VP, Reimbursement, Policy Insights, Cencora, provides a look at his recent webinar focused on the implications of the Inflation Reduction Act. 

Cencora VP of Reimbursement & Policy Insights Discusses Implications of the Inflation Reduction Act

An investigation evaluates whether SNAP benefits can also influence hypertension patients’ lack of medication adherence. 

Does Food Insecurity Impact Adherence to Antihypertensive Medications?

Compared with piperacillin/tazobactam, Exblifep (cefepime/enmetazobactam) showed noninferiority and superiority in a clinical cure and microbiological eradication of complicated urinary tract infections.

FDA Approves Antibiotic Combination for Complicated Urinary Tract Infections 

Current production of Qdenga will increase to 50 million doses a year. 

Takeda, Biological E. Team Up to Provide Dengue Vaccine Access to Endemic Countries

Epkinly (epcoritamab-bysp), a subcutaneously administered, T-cell engaging, bispecific antibody, was previously granted Breakthrough Therapy Designation for the treatment of patients with relapsed or refractory follicular lymphoma following two or more prior lines of therapy.

Featured Content

Pharmaceutical Commerce - December 2024

Did Industry Fumble the DSCSA Deadline?

Going Inside the Gross-to-Net Bubble and Its Nuances

Why AI Advances in CGT Require Getting Data Right